Wellington Management Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-83,302
| Closed | -$100K | – | 1893 |
|
|
2019
Q4 | $100K | Sell |
83,302
-1,513,299
| -95% | -$1.82M | ﹤0.01% | 1996 |
|
|
2019
Q3 | $2.41M | Buy |
1,596,601
+96,474
| +6% | +$146K | ﹤0.01% | 1537 |
|
|
2019
Q2 | $6.03M | Hold |
1,500,127
| – | – | ﹤0.01% | 1333 |
|
|
2019
Q1 | $6.45M | Hold |
1,500,127
| – | – | ﹤0.01% | 1317 |
|
|
2018
Q4 | $8.63M | Hold |
1,500,127
| – | – | ﹤0.01% | 1226 |
|
|
2018
Q3 | $20.3M | Sell |
1,500,127
-43,239
| -3% | -$586K | ﹤0.01% | 1079 |
|
|
2018
Q2 | $18.3M | Buy |
1,543,366
+35,401
| +2% | +$420K | ﹤0.01% | 1109 |
|
|
2018
Q1 | $16.9M | Buy |
1,507,965
+906,087
| +151% | +$10.2M | ﹤0.01% | 1125 |
|
|
2017
Q4 | $4.02M | Sell |
601,878
-15,125
| -2% | -$101K | ﹤0.01% | 1536 |
|
|
2017
Q3 | $5.05M | Buy |
617,003
+50,450
| +9% | +$413K | ﹤0.01% | 1468 |
|
|
2017
Q2 | $2.54M | Sell |
566,553
-42,080
| -7% | -$189K | ﹤0.01% | 1632 |
|
|
2017
Q1 | $3.35M | Buy |
608,633
+90,110
| +17% | +$497K | ﹤0.01% | 1594 |
|
|
2016
Q4 | $2.1M | Sell |
518,523
-55,200
| -10% | -$224K | ﹤0.01% | 1665 |
|
|
2016
Q3 | $4.05M | Buy |
573,723
+47,600
| +9% | +$336K | ﹤0.01% | 1452 |
|
|
2016
Q2 | $4.29M | Sell |
526,123
-7,520
| -1% | -$61.3K | ﹤0.01% | 1389 |
|
|
2016
Q1 | $4.34M | Sell |
533,643
-46,530
| -8% | -$378K | ﹤0.01% | 1394 |
|
|
2015
Q4 | $7M | Buy |
+580,173
| New | +$7M | ﹤0.01% | 1272 |
|